TCM Biotech International Corp.

TPEX:4169 Stock Report

Market Cap: NT$3.6b

TCM Biotech International Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for TCM Biotech International.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth46.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

Low

Last updated23 Feb 2024

Recent future growth updates

No updates

Recent updates

Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Jan 31
Can You Imagine How TCM Biotech International's (GTSM:4169) Shareholders Feel About The 28% Share Price Increase?

Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

Jan 04
Key Things To Consider Before Buying TCM Biotech International Corp. (GTSM:4169) For Its Dividend

We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

Dec 07
We Think TCM Biotech International (GTSM:4169) Can Stay On Top Of Its Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as TCM Biotech International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TPEX:4169 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20241,08234-10-51
6/30/2024834204750N/A
3/31/20249021926N/A
12/31/202397019-42-38N/A
9/30/202393216-13-7N/A
6/30/2023895131724N/A
3/31/2023849163238N/A
12/31/2022802184752N/A
9/30/2022761134045N/A
6/30/202272083438N/A
3/31/202271152126N/A
12/31/20217022815N/A
9/30/2021694-2-23-10N/A
6/30/2021686-5-53-34N/A
3/31/202171210020N/A
12/31/2020737265375N/A
9/30/2020719347288N/A
6/30/20207004291101N/A
3/31/2020635243240N/A
12/31/20195697-28-21N/A
9/30/201956410-28-6N/A
6/30/201956013-289N/A
3/31/201955019-2318N/A
12/31/201854025-1827N/A
9/30/201853422-3112N/A
6/30/201852719-44-2N/A
3/31/201853419N/A30N/A
12/31/201754119N/A63N/A
9/30/201753522N/A32N/A
6/30/201752925N/A2N/A
3/31/201751829N/A-35N/A
12/31/201650633N/A-71N/A
9/30/201649432N/A-39N/A
6/30/201648331N/A-7N/A
3/31/201647626N/A2N/A
12/31/201547021N/A12N/A
9/30/201543025N/AN/AN/A
6/30/201539029N/A52N/A
3/31/201535229N/A51N/A
12/31/201431429N/A50N/A
9/30/201432329N/AN/AN/A
6/30/201433329N/A17N/A
3/31/201432422N/A15N/A
12/31/201331616N/A12N/A
9/30/201329811N/A10N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 4169's forecast earnings growth is above the savings rate (1%).

Earnings vs Market: Insufficient data to determine if 4169's earnings are forecast to grow faster than the TW market

High Growth Earnings: Insufficient data to determine if 4169's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 4169's revenue is forecast to grow faster than the TW market.

High Growth Revenue: Insufficient data to determine if 4169's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if 4169's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y